Diginomica: As Veeva and Salesforce go their separate ways, why it's all to play for in the Life Sciences market As Veeva and Salesforce go their separate ways, why it's all to play for in the Life Sciences market I reiterate my 'Buy' rating on Veeva Systems, driven by accelerating Vault CRM adoption and robust R&D Solutions growth. VEEV's successful enterprise migrations and a 9-to-3 top-20 pharma win ... Our CRM business is healthy, and it is an important part of Veeva, but it's not the major -- it's not the largest part of Veeva anymore, that’s for sure.

Understanding the Context

A significant statement from Peter Gassner, ... Is VEEV a good stock to buy? We came across a bullish thesis on Veeva Systems Inc. on LongTermValue Research’s Substack.

Key Insights

In this article, we will summarize the bulls’ thesis on VEEV. Veeva Systems Inc ... We came across a bullish thesis on Veeva Systems Inc. on Compounding Your Wealth’s Substack by Sergey. In this article, we will summarize the bulls’ thesis on VEEV.

Final Thoughts

Veeva Systems Inc.'s share was ... Veeva Systems markets a suite of software services geared toward the biopharmaceutical industry. A wholly owned customer relationship management service is gaining steam for Veeva Systems. With access ... During the last three months, 9 analysts shared their evaluations of Veeva Systems (NYSE:VEEV), revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their ...